Company: SYRA
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001493152-25-022023
Chunk: 7

Company: Syra Health Corp
Filing Date: 2025-11-12
Form: 10-Q
Item: Item 1
Chunk 7
---
 issued for services 
     -  
     -  
     -  
     -  
     -  
     -  
     14,023  
     -  
     14,023 

    Net
    loss 
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     (417,535) 
     (417,535)

    Balance, September 30,
    2024 
     -  
    $-  
     8,973,774  
    $8,974  
     833,334  
    $833  
    $11,640,642  
    $(8,319,796) 
    $3,330,653 
  
    Balance 
     -  
    $-  
     8,973,774  
    $8,974  
     833,334  
    $833  
    $11,640,642  
    $(8,319,796) 
    $3,330,653 

See
accompanying notes to condensed unaudited financial statements.

F-4

SYRA
HEALTH CORP.

CONDENSED
STATEMENTS OF CASH FLOWS

(Unaudited)

    2025  
    2024 

    For the Nine Months Ended 

    June 30, 

    2025  
    2024 
  
    CASH FLOWS FROM OPERATING ACTIVITIES 

    Net loss 
    $(761,763) 
    $(3,254,841)
  
    Adjustments to reconcile net loss to net cash used in operating activities: 

    Depreciation 
     18,171  
     55,460 
  
    Common stock issued for services 
     2,586  
     74,647 
  
    Non-cash lease expense 
     -  
     63,199 
  
    Stock-based compensation, stock options 
     75,194  
     28,486 
  
    Changes in operating assets and liabilities: 

    Accounts receivable 
     (245,428) 
     176,189 
  
    Accounts receivable, related party 
     -